Pesquisa
Educação
Soluções
Entrar
PT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Center for Innovative Cancer Research
Jean-Simon Diallo has not added Biography.
If you are Jean-Simon Diallo and would like to personalize this page please email our Author Liaison for assistance.
Expression and nuclear localization of ErbB3 in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2006 | Pubmed ID: 16675564
An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines.
The Prostate Sep, 2006 | Pubmed ID: 16705740
Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.
Molecular cancer research : MCR Jan, 2007 | Pubmed ID: 17259348
NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells.
Cellular signalling May, 2007 | Pubmed ID: 17292587
Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer.
BJU international Aug, 2007 | Pubmed ID: 17532856
NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2007 | Pubmed ID: 18056181
Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
BJU international May, 2008 | Pubmed ID: 18294307
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.
Proceedings of the National Academy of Sciences of the United States of America Sep, 2008 | Pubmed ID: 18815361
Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines.
The Prostate May, 2009 | Pubmed ID: 19170126
Intelligent design: combination therapy with oncolytic viruses.
Molecular therapy : the journal of the American Society of Gene Therapy Feb, 2010 | Pubmed ID: 20029399
Synergistic interaction between oncolytic viruses augments tumor killing.
Molecular therapy : the journal of the American Society of Gene Therapy May, 2010 | Pubmed ID: 20234341
A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers.
Molecular therapy : the journal of the American Society of Gene Therapy Jun, 2010 | Pubmed ID: 20389287
A novel method of cell embedding for tissue microarrays.
Histopathology Aug, 2010 | Pubmed ID: 20716176
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors.
PloS one , 2010 | Pubmed ID: 21283510
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma.
Molecular therapy : the journal of the American Society of Gene Therapy Oct, 2011 | Pubmed ID: 21772252
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.
Nature Sep, 2011 | Pubmed ID: 21886163
Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains.
Methods in molecular biology (Clifton, N.J.) , 2012 | Pubmed ID: 21948474
The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers.
Molecular therapy : the journal of the American Society of Gene Therapy Dec, 2011 | Pubmed ID: 22186794
Ottawa Hospital Research Institute (OHRI)
Ottawa Hospital Research Institute
University of Ottawa
Jean-Simon Diallo1,
Dominic Roy1,
Hesham Abdelbary1,
Naomi De Silva1,
John C. Bell1
1Center for Innovative Cancer Research, Ottawa Hospital Research Institute (OHRI)
Vanessa Garcia1,2,
Ramya Krishnan1,2,
Colin Davis1,2,
Cory Batenchuk1,2,
Fabrice Le Boeuf1,3,
Hesham Abdelbary1,3,
Jean-Simon Diallo1,2
1Center for Innovative Cancer Research, Ottawa Hospital Research Institute,
2Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa,
3Faculty of Medicine, University of Ottawa
Privacidade
Termos de uso
Políticas
Entre em contato
recomende à biblioteca
Newsletter
JoVE Journal
Coleções de métodos
JoVE Encyclopedia of Experiments
Arquivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de Recursos para Docentes
Autores
Bibliotecários
Acesso
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados